Digital dilemma in UK’s life sciences job market
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
Pharma Mirror
JANUARY 19, 2024
As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 27, 2023
Digital transformation has much to offer life sciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.
Pharmaceutical Technology
MARCH 5, 2024
The UK Government announced plans to bolster the UK life science manufacturing industry through increased investment.
Pharmaceutical Technology
APRIL 20, 2023
European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn).
pharmaphorum
MARCH 8, 2024
Celebrate International Women’s Day by learning about Miruna Sasu, a prominent female figure in the life sciences field and CEO of COTA. Explore how the company uses AI in the oncology space.
pharmaphorum
MARCH 8, 2024
Angie Franks is a prominent female figure in the life sciences industry and perfect to highlight on International Women's Day. Learn more about her contributions and achievements in healthcare and technology.
Cloudbyz
MARCH 17, 2024
In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.
Bio Pharma Dive
DECEMBER 11, 2023
Research from Everest Group shows how life sciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.
Pharmaceutical Technology
APRIL 14, 2023
Biotechnology company Tiziana Life Sciences has revealed plans to assess intranasal foralumab as a potential treatment for long Covid. Tiziana Life Sciences chief medical officer Matthew Davis said: “We anticipate entering into a Phase 2a placebo-controlled clinical trial upon successful feedback from the FDA.
BioSpace
MARCH 18, 2024
BioSpace's 2024 Salary Report explores the average salaries and salary trends of life sciences professionals.
pharmaphorum
MARCH 18, 2024
Discover the top 7 challenges faced by pharmaceutical and life sciences companies in achieving patient-centricity and engaging healthcare professionals (HCPs). Explore strategies to overcome these obstacles for successful outreach efforts.
Bio Pharma Dive
DECEMBER 12, 2022
Learn about the investment landscape for life science companies, heading into 2023.
Pharmaceutical Technology
NOVEMBER 7, 2023
The UK National Institute for Health and Care Excellence (NICE) unveils refreshed support service, NICE Advice, for the life sciences sector.
Bio Pharma Dive
APRIL 19, 2023
Forbion and Gilde Healthcare raised a combined $2 billion across their respective funds to invest in emerging biotech and life sciences companies.
Pharmaceutical Technology
NOVEMBER 25, 2022
XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The post XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform appeared first on Pharmaceutical Technology.
Pharmaceutical Technology
OCTOBER 24, 2023
INVO Bioscience has signed an agreement to acquire NAYA Biosciences to establish a publicly traded life science company.
Pharmaceutical Technology
DECEMBER 4, 2023
Blarcamesine hydrochloride is under clinical development by Anavex Life Sciences and currently in Phase I for Infantile Spasm (West Syndrome).… …
pharmaphorum
JANUARY 25, 2024
Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.
Pharma Times
SEPTEMBER 28, 2023
Initiative has been designed to support career advancement for women across the life sciences - News - PharmaTimes
XTalks
FEBRUARY 15, 2024
In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine.
Bio Pharma Dive
OCTOBER 25, 2023
This podcast series explores how life sciences companies can bolster their cybersecurity while growing their business.
Bio Pharma Dive
FEBRUARY 7, 2024
The new firm intends to carefully select its startups and fund them for the long haul. “We're not a company formation factory,” said Aaron Kantoff, the firm’s co-founder.
pharmaphorum
FEBRUARY 29, 2024
Explore the impact of the Inflation Reduction Act (IRA) on drug prices and negotiations within the life sciences industry, as it stands on the threshold of change. Gain insights into the potential outcomes and implications of this legislation.
pharmaphorum
JANUARY 10, 2024
Explore the latest trends and projections in life sciences real estate, including the impact of digital health, the evolving needs of laboratory facilities, and the future of real estate in this sector. Stay ahead of the curve with insights into the industry's future.
pharmaphorum
NOVEMBER 16, 2023
Life sciences inspections and investigations Mike.Hammerton Thu, 16/11/2023 - 10:23 Bookmark this
XTalks
MARCH 20, 2024
In this featured episode of Xtalks People in Life Sciences, Ayesha spoke with Ashish Jain, Senior Director of Clinical Safety and Pharmacovigilance (PV) at Curis , a pioneering biotech company specializing in cutting-edge cancer therapies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Pharmaceutical Technology
AUGUST 24, 2023
As the UK economy slowly recovers, the life sciences sector is seeking candidates with data skills amid slow workforce growth.
XTalks
JANUARY 24, 2024
In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Read the full article here: Life Science Trends to Look Out for in 2024 The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
pharmaphorum
MARCH 5, 2024
Explore how innovation is shaping the future of life sciences through digital transformation and AI. Learn how incorporating cutting-edge technologies can drive success in the industry.
Pharmaceutical Technology
SEPTEMBER 22, 2023
Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in Glenmark Life Sciences for $679.85m.
pharmaphorum
DECEMBER 8, 2023
Life sciences industry predictions 2024: Curavit Mike.Hammerton Fri, 08/12/2023 - 14:15 Bookmark this
Pharmaceutical Technology
JULY 28, 2022
In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country.
Pharmaceutical Technology
NOVEMBER 8, 2022
Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. Famy Life Sciences has an ophthalmology portfolio that complements Viatris. Viatris plans to finance these purchases in cash.
Bio Pharma Dive
MARCH 14, 2022
Value-focused solutions can help life sciences groups make the switch to value-based contracting.
Pharmaceutical Technology
OCTOBER 16, 2023
We explore how the life sciences industry can address these challenges to create a secure and compliant health data ecosystem. Pharma and healthcare organisations use patient data to deliver personalised treatments and efficient care, but the digitalisation of the industry raises new privacy and cybersecurity concerns.
pharmaphorum
SEPTEMBER 15, 2023
Driving data & analytics transformation in life sciences Mike.Hammerton Fri, 15/09/2023 - 08:00 Bookmark this
Drug Discovery World
MARCH 15, 2024
Valneva Scotland scooped two prizes at Scotland’s Life Sciences Awards 2024, including the award for Innovation – Pharma Services And Drug Discovery, in a ceremony on 14 March in Glasgow. billion of contribution to the Scottish economy, the success of the life sciences sector is phenomenal.
Pharmaceutical Technology
MARCH 26, 2024
Ingersoll Rand has signed an agreement for the acquisition of ILC Dover for an upfront cash purchase price of approximately $2.325bn.
Pharma Mirror
SEPTEMBER 6, 2023
Why Is Patient-Centric Marketing The post Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs appeared first on Pharma Mirror Magazine.
Pharma Mirror
SEPTEMBER 6, 2021
and operates the TANAKA Precious Metals manufacturing business, announced today that TANAKA made an equity contribution to Ambix Life Science Fund I, L.P., The post TANAKA Contributes to Ambix Life Science Fund appeared first on Pharma Mirror Magazine. Background to and Objectives.
Pharmaceutical Technology
JUNE 16, 2023
for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai start-up.ai
pharmaphorum
OCTOBER 10, 2023
South Korea: Emerging global leader in life sciences Mike.Hammerton Wed, 11/10/2023 - 05:30 Bookmark this
Drug Channels
MARCH 18, 2024
Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered!
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content